MUMBAI, India and NAPLES, Fla., June 26, 2026 /CNW/ — Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: ...

Lupin secures tentative USFDA nod for generic Enzalutamide tablets, paving the way for future entry into the prostate cancer ...

Netflix is officially bringing back a fan-favorite heist drama after a three-year hiatus. The long wait is almost over, as Lupin Part 4 has finally secured a premiere date. The streaming giant ...

Lupin secures tentative USFDA approval for generic enzalutamide tablets for castration‑resistant prostate cancer, including ...

Lupin receives tentative US FDA approval for Enzalutamide Tablets, offering new dosing options as a bioequivalent to Xtandi.

Record-breaker, non-English mystery-thriller series is returning! Know everything about Lupin Part 4 release date, cast, ...

Lupin receives USFDA tentative approval for its generic enzalutamide tablets, a prostate cancer treatment. Bioequivalent to ...

Netflix confirmed when "Lupin,' one of the streamer's best-reviewed mystery thriller shows, will return for Season 4.

This five-episode Part 2 is really a season-ette, since it’s the second half of the first part which appeared in January. That left viewers dangling nervously, as it ended with the abduction of Assane ...

According to the company, the US FDA has found Lupin's 40 mg and 80 mg tablets to be bioequivalent to Astellas Pharma's ...

Mumbai-based Lupin Ltd has secured tentative US FDA approval for Enzalutamide Tablets in multiple strengths, offering ...